A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
Luckily for you, we built StockStory to help you separate the good from the bad. Keeping that in mind, here are two cash-producing companies that leverage their financial strength to beat the competition and one that may face some trouble.
One Stock to Sell:
Bio-Techne (TECH)
Trailing 12-Month Free Cash Flow Margin: 21.7%
With a catalog of hundreds of thousands of specialized biological products used in laboratories worldwide, Bio-Techne (NASDAQ: TECH) develops and manufactures specialized reagents, instruments, and services that help researchers study biological processes and enable diagnostic testing and cell therapy development.
Why Do We Pass on TECH?
- Organic sales performance over the past two years indicates the company may need to make strategic adjustments or rely on M&A to catalyze faster growth
- Smaller revenue base of $1.22 billion means it hasn’t achieved the economies of scale that some industry juggernauts enjoy
- Diminishing returns on capital from an already low starting point show that neither management’s prior nor current bets are going as planned
Bio-Techne is trading at $72.61 per share, or 35.7x forward P/E. Read our free research report to see why you should think twice about including TECH in your portfolio.
Two Stocks to Watch:
Lennox (LII)
Trailing 12-Month Free Cash Flow Margin: 14.2%
Based in Texas and founded over a century ago, Lennox (NYSE: LII) is a climate control solutions company offering heating, ventilation, air conditioning, and refrigeration (HVACR) goods.
Why Are We Fans of LII?
- Excellent operating margin of 17.7% highlights the efficiency of its business model, and it turbocharged its profits by achieving some fixed cost leverage
- Free cash flow margin increased by 8.6 percentage points over the last five years, giving the company more capital to invest or return to shareholders
- ROIC punches in at 37.3%, illustrating management’s expertise in identifying profitable investments
Lennox’s stock price of $377.25 implies a valuation ratio of 14.8x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.
Accenture (ACN)
Trailing 12-Month Free Cash Flow Margin: 17.2%
With a workforce of approximately 774,000 people serving clients in more than 120 countries, Accenture (NYSE: ACN) is a professional services firm that helps organizations transform their businesses through consulting, technology, operations, and digital services.
Why Does ACN Stand Out?
- Annual revenue growth of 8.8% over the last five years beat the sector average and underscores the unique value of its offerings
- Enormous revenue base of $73.1 billion provides significant distribution advantages
- Stellar returns on capital showcase management’s ability to surface highly profitable business ventures
At $176.49 per share, Accenture trades at 12.4x forward P/E. Is now the time to initiate a position? See for yourself in our comprehensive research report, it’s free.
Stocks We Like Even More
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.
